Skip to main content
Craig Sauter, MD, Hematology, Cleveland, OH, Cleveland Clinic

CraigSauterMD

Hematology Cleveland, OH

Hematologic Oncology

Director, Blood and Marrow Transplant Program Cleveland Clinic

Dr. Sauter is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Sauter's full profile

Already have an account?

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2006 - 2009
  • University of Michigan Health System
    University of Michigan Health SystemResidency, Internal Medicine, 2003 - 2006
  • Case Western Reserve University School of Medicine
    Case Western Reserve University School of MedicineClass of 2003

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2006 - 2025
  • OH State Medical License
    OH State Medical License 2022 - 2024
  • NC State Medical License
    NC State Medical License 2021 - 2022
  • American Board of Internal Medicine Hematology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Strategies to Improve Outcomes of Autologous Hematopoietic Cell Transplant in Lymphoma  
    Parastoo B Dahi, Hillard M Lazarus, Sergio A Giralt, Craig S Sauter, Nature

Abstracts/Posters

  • MSKCC Early Experience Using Radiotherapy As a Bridging Strategy for Relapsed Diffuse Large B Cell Lymphoma before CD19 CAR T Therapy
    Craig S. Sauter, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Highly Favorable Outcomes with Salvage Radiation Therapy Followed By Autologous Transplant in Relapsed and Refractory DLBCL Patients with Minimal or No Response to Sal...
    Craig S. Sauter, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Allogeneic Stem Cell Transplantation (alloHSCT) for Chronic Lymphocytic Leukemia (CLL) in the Era of Novel Agents
    Craig S. Sauter, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Lectures

  • Double-Unit Cord Blood (CB) Transplantation with Haplo-Identical CD34+ Cells (haplo-dCBT) May Speed Neutrophil Recovery Although Successful Bridging Is Contingent on C... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • The Prognostic Calculator Easix Predicts Acute Gvhd, Non-Relapse Mortality and Overall Survival in Adult Patients Undergoing Reduced Intensity Conditioning Allogeneic HCT 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • A Simple Geriatric Vulnerability Index for Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • World Leukemia Day: CAR T-cell Therapy Offers Hope to Leukemia Patients, Even Where Other Treatments Have Failed
    World Leukemia Day: CAR T-cell Therapy Offers Hope to Leukemia Patients, Even Where Other Treatments Have FailedSeptember 1st, 2022
  • Dr. Sauter on CAR T-cells in Real-World Patients with Hematologic Malignancies
    Dr. Sauter on CAR T-cells in Real-World Patients with Hematologic MalignanciesFebruary 21st, 2020
  • CD19-Specific CAR T-cell Therapy Feasible for Aggressive Non-Hodgkin Lymphoma
    CD19-Specific CAR T-cell Therapy Feasible for Aggressive Non-Hodgkin LymphomaJuly 23rd, 2019
  • Join now to see all

Hospital Affiliations